Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envarsus versus Advagraf pharmacokinetic study in de novo adult kidney transplant recipients
2014-005572-28Phase 4Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- May 2015
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus in kidney transplant immunosuppression (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Pharmacokinetic and dose adjustment variables. Started May 2015; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplant immunosuppression
Beyond the preview
Go deeper on 2014-005572-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005572-28.